Archive: 01/02/2013
Ravicti approved for urea cycle disorders
(HealthDay)—Ravicti (glycerol phenylbutyrate) has been approved by the U.S. Food and Drug Administration to treat certain urea cycle disorders (UCDs) in people 2 years and older.
Feb 1, 2013
Half of world countries unprepared to deal with cancer, WHO says
Less than half of all countries in the world have functioning plans to prevent cancer and provide treatment and care to cancer patients, the World Health Organisation lamented Friday.
Feb 1, 2013
Caring friends can save the world
Craig Kielburger was only 12 years old when he travelled to India to see the plight of child laborers first hand. 14-year-old Malala Yousafzai took a stand against the Taliban with her campaign for women's education rights. ...
Feb 1, 2013
Propping open the door to the blood brain barrier
The treatment of central nervous system (CNS) diseases can be particularly challenging because many of the therapeutic agents such as recombinant proteins and gene medicines are not easily transported across the blood-brain ...
Feb 1, 2013
Group Therapy: New approach to psychosis treatment could target multiple nervous system receptors
Antipsychotic drugs, used in the treatment of psychotic disorders involving severe delusions and hallucinations, have been studied for more than 70 years. Currently available antipsychotic drugs, however, only alleviate certain ...
Feb 1, 2013
Humanitarian aid workers in Uganda show signs of stress, depression, and burnout
Latest research points to the high risk for mental health problems among staff working in humanitarian organizations in northern Uganda, due in large part to their work environment. A new study by researchers at Columbia's ...
Feb 1, 2013
Autism speaks through gene expression
Autism spectrum disorders affect nearly 1 in 88 children, with symptoms ranging from mild personality traits to severe intellectual disability and seizures. Understanding the altered genetic pathways is critical for diagnosis ...
Feb 1, 2013
Type II diabetes and the Alzheimer's connection
A research team in Israel has devised a novel approach to identifying the molecular basis for designing a drug that might one day decrease the risk diabetes patients face of developing Alzheimer's disease. The team will present ...
Feb 1, 2013